INTERNATIONAL PATENT: OSE IMMUNOTHERAPEUTICS FILES APPLICATION FOR "THERAPY BY ANTAGONIZING IL-7 OR CD127 AND IL-12, IL-23, IL-12R OR IL-23R"

GENEVA, March 30 -- OSE IMMUNOTHERAPEUTICS (22, boulevard Benoni Goullin44200 NANTES) filed a patent application (PCT/EP2025/077230) for "THERAPY BY ANTAGONIZING IL-7 OR CD127, AND IL-12, IL-23, IL-12R OR IL-23R" on Sep 23, 2025. With publication no. WO/2026/062296, the details related to the patent application was published on Mar 26, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): POIRIER, Nicolas (4 impasse de la Rochere44119 GRANDCHAMPS DES FONTAINES), MARY, Caroline (3 Les Glands44680 SAINTE-PAZANNE), BELARIF, Lyssia (24 Rue Georges Boutin44400 Reze), MORELLO, Aurore (18 bis rue de l'Ou...